Lyzed by intent to treat. Blood 106, 2005 (abstr 2679) 33. Damaj G, Gressin R
Lyzed by intent to treat. Blood 106, 2005 (abstr 2679) 33. Damaj G, Gressin R, Bouabdallah K, et al: Final results from a potential, openlabel, phase II trial of bendamustine…